PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
-2.53%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$2.17B
AUM Growth
+$2.17B
(-8.4%)
Cap. Flow
-$68.3M
Cap. Flow
% of AUM
-3.15%
Top 10 Holdings %
Top 10 Hldgs %
36.12%
Holding
88
New
9
Increased
22
Reduced
22
Closed
13
Top Buys
| 1 |
Becton Dickinson
BDX
|
$37.4M |
| 2 |
DexCom
DXCM
|
$33.5M |
| 3 |
Legend Biotech
LEGN
|
$22.8M |
| 4 |
Acadia Healthcare
ACHC
|
$22.5M |
| 5 |
Ascendis Pharma
ASND
|
$21.7M |
Top Sells
| 1 |
Cigna
CI
|
$46.8M |
| 2 |
Biogen
BIIB
|
$43.1M |
| 3 |
AstraZeneca
AZN
|
$39.1M |
| 4 |
Axsome Therapeutics
AXSM
|
$30M |
| 5 |
Agilent Technologies
A
|
$27.5M |
Sector Composition
| 1 | Healthcare | 95.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Becton Dickinson
BDX
$55.3B
| $37.4M | 1.65% |
+151,013
| New | +$37.4M |
|
27
Dynavax Technologies
DVAX
$1.19B
| $37.3M | 1.65% |
3,805,370
| – | – |
|
28
Thermo Fisher Scientific
TMO
$186B
| $35.8M | 1.58% |
62,143
| – | – |
|
|
ISEE
29
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $35.7M | 1.57% |
1,465,483
+547,926
| +60% | +$13.3M |
|
30
Universal Health Services
UHS
$11.6B
| $29.7M | 1.31% |
233,685
+109,264
| +88% | +$13.9M |
|
31
Waters Corp
WAT
$18B
| $29.3M | 1.29% |
94,624
| – | – |
|
32
Avantor
AVTR
$9.18B
| $28.6M | 1.26% |
1,351,326
-256,286
| -16% | -$5.42M |
|
33
Arcus Biosciences
RCUS
$1.13B
| $28.5M | 1.26% |
1,559,947
-1,143,340
| -42% | -$20.9M |
|
34
Caribou Biosciences
CRBU
$174M
| $26.6M | 1.18% |
5,012,118
+552,335
| +12% | +$2.93M |
|
|
KRTX
35
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $25.1M | 1.11% |
138,209
+7,916
| +6% | +$1.44M |
|
|
PNT
36
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $23.3M | 1.03% |
3,204,790
-1,429,012
| -31% | -$10.4M |
|
|
37
Legend Biotech
LEGN
$6.41B
| $22.8M | 1.01% |
+472,161
| New | +$22.8M |
|
|
38
Acadia Healthcare
ACHC
$2.12B
| $22.5M | 0.99% |
+310,935
| New | +$22.5M |
|
|
39
Ascendis Pharma
ASND
$11.8B
| $21.7M | 0.96% |
+202,115
| New | +$21.7M |
|
40
Tenet Healthcare
THC
$16.3B
| $21.2M | 0.94% |
356,941
+102,416
| +40% | +$6.09M |
|
41
ICU Medical
ICUI
$3.15B
| $20.2M | 0.89% |
+122,703
| New | +$20.2M |
|
42
Apellis Pharmaceuticals
APLS
$3.48B
| $18.8M | 0.83% |
284,269
-34,153
| -11% | -$2.25M |
|
43
BioCryst Pharmaceuticals
BCRX
$1.74B
| $18M | 0.8% |
2,162,411
| – | – |
|
44
Arcellx
ACLX
$3.85B
| $16.2M | 0.72% |
525,816
-90,699
| -15% | -$2.79M |
|
45
BioMarin Pharmaceuticals
BMRN
$11.2B
| $15.5M | 0.69% |
159,566
-150,835
| -49% | -$14.7M |
|
46
Elevance Health
ELV
$71.8B
| $15M | 0.66% |
32,583
-34,532
| -51% | -$15.9M |
|
|
BLUE
47
DELISTED
bluebird bio
BLUE
| $14.6M | 0.64% |
4,585,782
+4,340,915
| +1,773% | +$13.8M |
|
48
Erasca
ERAS
$445M
| $14.4M | 0.64% |
4,797,460
| – | – |
|
49
Icon
ICLR
$13.8B
| $13.8M | 0.61% |
64,417
-17,308
| -21% | -$3.7M |
|
50
ESSA Pharma
EPIX
$11.4M
| $12.4M | 0.55% |
4,161,461
+317,129
| +8% | +$942K |
|